Paul Thielking
Chief Tech/Sci/R&D Officer at NUMINUS WELLNESS INC.
Net worth: - $ as of 2024-03-30
Profile
Paul Thielking is currently the Chief Science Officer at Numinus Wellness, Inc. Prior to this, he worked as the Director of Psycho Oncology at Huntsman Cancer Institute, an Associate Professor at the University of Utah, and the Chief Scientific Officer at Novamind, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
NUMINUS WELLNESS INC
-.--% | 2023-05-31 | 0 ( -.--% ) | - $ | 2024-03-30 |
Paul Thielking active positions
Companies | Position | Start |
---|---|---|
NUMINUS WELLNESS INC. | Chief Tech/Sci/R&D Officer | 2022-06-09 |
Former positions of Paul Thielking
Companies | Position | End |
---|---|---|
Huntsman Cancer Institute | Corporate Officer/Principal | - |
University of Utah | Corporate Officer/Principal | - |
NOVAMIND INC. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NUMINUS WELLNESS INC. | Health Services |
Private companies | 2 |
---|---|
Novamind, Inc.
Novamind, Inc. Medical/Nursing ServicesHealth Services Novamind, Inc. is a mental health company, which engages in enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. It offers outpatient mental health services, and provides clinical trial services through its subsidiary. It operates through the Cedar Psychiatry and Cedar Clinical Research business divisions. The company was founded by Yaron Conforti, Jesse Kaplan, and Sruli Weinreb on April 23, 1997 and is headquartered in Toronto, Canada. | Health Services |
Huntsman Cancer Institute |
- Stock Market
- Insiders
- Paul Thielking